Elsevier Journals to Link Published Reports of Clinical Trials to the Registered Study

Oxford, UK, June 20, 2016

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that it will participate in a multi-publisher pilot project led by Crossref. As part of the project, several of Elsevier’s leading journals will share details of registered clinical trials with Crossref so that they can be linked to studies that were published as a result of the trial.

For papers that report on clinical trials, Elsevier and other participating publishers will provide Crossref with the DOI and clinical trial number (CTN) of the article. This will create a linked network of papers relevant to individual clinical trials. As a result, studies that were derived from one trial, but that were published by different publishers years apart can now be linked. Researchers can find studies linked to clinical trials by clicking the CrossMark logo on a particular trial report or by using Crossref open APIs.

Initially, 20 leading health and medical science journals will participate in the pilot, including The Lancet, the European Journal of Cancer and the American Journal of Cardiology. Other health and medical science journals will be added after the initial test phase.

Linking studies to the clinical trial registration will enhance readers’ understanding of the full results that came out of a trial, making scientific reporting more transparent. It will also enable readers to more easily measure the results of trials against their original aims.

The clinical trial registries involved in the pilot are endorsed by the World Health Organization and include ClinicalTrials.gov, the UTN and ISRCTN registries, along with several leading national registries, such as the Chinese Clinical Trial Registry.

Discussing the project, David Clark, Senior Vice President, Health & Medical Sciences at Elsevier, commented: ‘Elsevier has identified over 5,000 records of clinical trial registrations amongst the first 20 journals included in this pilot, with many more journals and accompanying clinical trial reports ready to be added after this pilot has launched. We are excited to use technology to improve the transparency of STM reporting.’

“These records from Elsevier will be a huge boost to this important multi-publisher initiative to increase the visibility of clinical trial reports,” said Kirsty Meddings, Product Manager at Crossref. “Elsevier has been one of the integral participants in planning the pilot, and we are excited to see the results start to come in.”

Read more on Elsevier Connect.


About Elsevier
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com

Media contact
Ash Allan
+44 1865 843745